ANVISA
Compounding pharmacies await new Anvisa rules to work with cannabidiol
Anvisa approves resolutions to regulate cannabis cultivation in Brazil
Anvisa proposes strict rules for cannabis cultivation for research purposes in Brazil
Anvisa proposes creation of “Regulatory Sandbox” for cannabis cultivation by associations
Colombia simplifies export of medicinal cannabis to Brazil after consulting ANVISA
22/01/2026The National Narcotics Fund (FNE) will no longer require Export Certificates for shipments destined to patients (Individuals) in Brazil, eliminating a bureaucratic obstacle that hindered the flow of derivatives between the two countries
2026 reserves crucial legislative advances for medical cannabis in Brazil
22/01/2026Resumption of Anvisa review and STJ deadline for cultivation define the sector's direction in the first quarter of the year
Anvisa receives letter questioning "requirement of criminal background check" for cannabis cultivation
22/01/2026Adesaf Institute points out unconstitutionality in vetoing workers with criminal history in research areas and requests review of measure
Anvisa Collegiate Board has new composition defined after director's departure
29/12/2025Marcelo Mario Matos Moreira takes over as substitute in the Fourth Board, filling the vacancy of the former rapporteur of the review of RDC 327
Anvisa approves new framework for herbal medicines in Brazil
19/12/2025New regulation simplifies registration and expands the use of biodiversity in herbal medicines, as soon as cannabis products are classified as medicines, they must comply with these standards.
RDC 327 review rapporteur bids farewell to Anvisa this Friday (19).
19/12/2025Rômison Rodrigues Mota leaves the position after a request for review delays the norm's vote; the topic will return to the regulatory agenda for 2026-2027
Researchers submit technical proposal to Anvisa for cannabis regulation
18/12/2025Group of 58 experts from public and private universities advocates for regulations based on scientific evidence for the cultivation and regulation of cannabis in Brazil
CFF advocates for magistral manipulation amid changes in Cannabis regulation
16/12/2025Entity reinforces that personalized preparations are essential when industrialized products do not meet clinical needs
Cannabis cultivation and regulatory review take center stage in the 2026–2027 Regulatory Agenda
15/12/2025Approved document defines 161 priority topics for the next two years, including national cultivation of low-THC cannabis
CRF-SP warns of risk of setback and legal uncertainty in the review of the Cannabis regulation
15/12/2025According to Marcelo Polacow Bisson, excluding pharmacies' manipulation leads to lack of assistance; Anvisa's proposed text on the Cannabis regulation is also criticized for bypassing procedural rites
Proposal to restrict Cannabis importation (RDC 660) sparks reaction in the market
12/12/2025Proposal in the review of RDC 327/2019 to RDC 660/2022 divides opinions and raises doubts about access and judicialization
RDC 327 vote postponed at Anvisa; ABIQUIFI evaluates new deadline as "legitimate tool"
11/12/2025Brazilian Association of Pharmaceutical Inputs Industry trusts that director Thiago Campos' request for review will result in a more thorough analysis, maintaining the expectation of regulatory framework completion in January 2026